187 related articles for article (PubMed ID: 8767035)
1. [Deficit schizophrenia: from pharmacology to clinical practice].
Tassin JP
Encephale; 1996 Jun; 22 Spec No 2():9-12. PubMed ID: 8767035
[TBL] [Abstract][Full Text] [Related]
2. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
Winterer G
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
Tanaka S
Neuroscience; 2006 Apr; 139(1):153-71. PubMed ID: 16324800
[TBL] [Abstract][Full Text] [Related]
4. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
5. Consensus on the use of substituted benzamides in psychiatric patients.
Racagni G; Canonico PL; Ravizza L; Pani L; Amore M
Neuropsychobiology; 2004; 50(2):134-43. PubMed ID: 15292667
[TBL] [Abstract][Full Text] [Related]
6. Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.
Yang CR; Chen L
Neuroscientist; 2005 Oct; 11(5):452-70. PubMed ID: 16151046
[TBL] [Abstract][Full Text] [Related]
7. [Psychopharmacologic approaches to schizophrenic psychoses].
Giacardy-Paty M; Soubrouillard C; Blin O
Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
[TBL] [Abstract][Full Text] [Related]
8. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
Maćkowiak M; Czyrak A; Wedzony K
Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs.
Lidow MS; Elsworth JD; Goldman-Rakic PS
J Pharmacol Exp Ther; 1997 Apr; 281(1):597-603. PubMed ID: 9103549
[TBL] [Abstract][Full Text] [Related]
10. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
11. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
12. Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics.
Gioanni Y; Thierry AM; Glowinski J; Tassin JP
Synapse; 1998 Dec; 30(4):362-70. PubMed ID: 9826228
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
14. [Biological markers in schizophrenia].
Lembreghts M; Ansseau M
Encephale; 1993; 19(5):501-23. PubMed ID: 8306920
[TBL] [Abstract][Full Text] [Related]
15. The neuropathology of schizophrenia.
Bachus SE; Kleinman JE
J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174
[TBL] [Abstract][Full Text] [Related]
16. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
17. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
18. A model of prefrontal cortex dopaminergic modulation during the delayed alternation task.
Dreher JC; Guigon E; Burnod Y
J Cogn Neurosci; 2002 Aug; 14(6):853-65. PubMed ID: 12191453
[TBL] [Abstract][Full Text] [Related]
19. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
Moxon KA; Gerhardt GA; Adler LE
Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]